It has now been over a decade since the human genome was first sequenced, but the utility of genomic findings in daily clinical medicine has grown at a snail’s pace. Recent advances in sequencing and genetic testing have lowered the cost of obtaining data on an individual patient, but research lags to provide solid guidance to clinicians, and patients, that will aid in diagnosis and treatment. Several recent pieces in the Journal of the American Medical Association focus on the role of genomics in medicine. In one, the authors discuss the need for better information systems to store and provide genomic information at the point of care. Current EHRs are not capable of storing the volume of information generated by genomic testing. And a useful information system would provide clinical decision support around genetic data, since most physicians do not feel they have adequate training in the field. (JAMA Article) Several articles in the current issue discuss other aspects of genomics in medical care and the research reports all deal with use of specific genetic findings in the diagnosis and treatment of disease. (JAMA Issue) The authors of several commentaries in this issue note the potential barriers to more widespread use of genomics, including cost, training of health professionals, privacy concerns and the usability of the data. Personalized medicine, which uses knowledge about the individual patient’s biochemistry, including not just raw genomic sequence, but also expression information, is a very appealing idea. But it requires that we have a very clear understanding of the linkage between the variations in that individual information and the clinical meaning of the variations. In a few areas, such as pharmacogenomics and cancer treatment, there is a good start, but for many widespread, chronic diseases, there is a need for much more research.
Genomics and Personalized Medicine
By Kevin RocheApril 15, 2013Commentary
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
Another example of over-priced companies trying to find some way to survive in the post-epidemic financial world. Transcarent, which does something, somehow to “access high quality, affordable care” is buying...
March 6, 2023
In an attempt to swiftly revive two floundering health care companies, a PE firm has announced the merger and recapitalization of Revive Health and SwiftMD. You know they are...
January 30, 2023
Investors have not yet learned their lesson, as Pearl Health gathers a new round of $75 million in capital for its business of supporting physicians who want to participate in...
January 30, 2023
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace
March 27, 2023
Why You Can’t Trust People Who Make Up Stuff About Vax Safety
A couple of studies offer a far better explanation for heart issues in athletes and…
March 25, 2023
Coronamonomania Lives Forever, Part 201
Tired of March Madness? A boringly refreshing dip into some CV-19 research summaries is recommended.
March 24, 2023
The CDC Is a Font of Methodological and Statistical Error
Several times in the last three years I and others have pointed out serious flaws…